Xenetic Biosciences, Inc.

menu
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Careers
  • Technology
    • Overview
    • PolyXen™
    • XBIO-101
    • Patents
    • Publications
  • Product Pipeline
    • Overview
    • XBIO-101
    • PolyXen
    • Research & Development
  • Clinical Trials
    • Recurrent or Persistent Endometrial Cancer Clinical Trial
  • Partners
  • News & Media
    • Press Releases
    • Presentations
    • Multimedia
  • Investors
    • Investor Relations
    • Overview
    • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
    • Analyst Coverage
    • Financial Info
    • Financials
    • Financial Results
    • Stock Data
    • Quote
    • Charts
    • Historical Data
    • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Governance
    • Board of Directors
    • Governance Documents
  • Contact
  • Xenetic Biosciences, Inc. on Twitter
  • Xenetic Biosciences, Inc. on Facebook
  • Xenetic Biosciences, Inc. on LinkedIn
  • Xenetic Biosciences, Inc. on Google+
Nasdaq: XBIO
News & Media

News & Media

  • Press Releases
  • Presentations
  • Multimedia

Presentations

Corporate Presentation

Corporate Presentation
PolyXen Case Study

PolyXen Case Study

Get Email Alerts

Stay informed about our latest new and updates

Sign up Today
© 2019Xenetic Biosciences, Inc.
  • Privacy Policy
  • Disclaimer
  • Sitemap